BioSpace News Archive

Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that created Swoop®, the world’s first FDA-cleared portable MRI system™, today announced that the company will be participating in the upcoming 40th Annual J.P. Morgan Healthcare Conference.

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global, clinical-stage biotechnology company developing and manufacturing novel therapies, will virtually participate in the 40th Annual J.P. Morgan Healthcare Conference.

Viveve Medical, Inc., a medical technology company focused on women’s health, announced that Scott Durbin, chief executive officer, will participate in the H.C. Wainwright BIOCONNECT Conference, January 10 - 13, 2022.

SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company” or “SciSparc”), marks today one of the Company’s most important milestones to date - the U.S. Patent and Trademark Office has granted it a new patent - U.S. Patent No. 11,207,290, titled combinations of cannabinoids and n-acylethanolamines (the “Patent”).

Dipharma Francis (“Dipharma”), a global CDMO and a leading manufacturer of APIs and intermediates for generic and contract manufacturing markets, is pleased to announce that Kalexsyn, Inc., a Michigan corporation (“Kalexsyn”) acquired in 2018, has been merged into its 100% owner, Dipharma Inc., a Delaware corporation and member of the Dipharma Group, effective January 01, 2022.

Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has approved new expanded magnetic resonance imaging (MRI) compatibility for its Proclaim™ XR Spinal Cord Stimulation (SCS) System with Octrode™ leads.

Citius Pharmaceuticals, Inc. announced that it will be presenting at two virtual conferences in January 2022.

Algernon Pharmaceuticals Inc. reports that the Company has granted 96,000 stock options exercisable at $4.10 for five years from date of grant, for officers and directors, employees and a consultant and are subject to approval by regulatory authorities.

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced proof-of-concept data generated using an Alzheimer’s disease mouse model, supporting the therapeutic potential of HT-ALZ.

Apollo Medical Holdings, Inc. today announced that Brandon Sim , Co-Chief Executive Officer, is scheduled to present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022, at 10:30 a.m. PT/1:30 p.m. ET.